Takeda Pharmaceutical
Yulan Shen, MBA, CEP, CCP, CECP, currently serves as Vice President and Head of Global Executive Compensation at Takeda since March 2023. Prior to this role, Yulan held various positions at Biogen from February 2016 to March 2023, including leadership in Global Pricing & Access for Neuromuscular Diseases and overseeing executive compensation and equity programs. Yulan's experience also includes working as Vice President and Executive Compensation Consultant at Pearl Meyer & Partners, where responsibilities involved advising senior management and Boards on executive compensation strategies and programs. Earlier at HNI Corporation, Yulan supported executive compensation matters for senior management and the Board. Yulan holds an MBA from The Wharton School, a Master's in Industrial Relations from Iowa State University, and a Bachelor's in Human Resources Management from Hohai University.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
177 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.